Multiplex Assay Kit for Interleukin 17F (IL17F) ,etc. by FLIA (Flow Luminescence Immunoassay)

ML-1

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Interleukin 17F (IL17F) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Interleukin 17F (IL17F) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Interleukin 17F (IL17F) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Interleukin 17F (IL17F) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 98-105 102
EDTA plasma(n=5) 98-105 101
heparin plasma(n=5) 92-105 101

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Interleukin 17F (IL17F) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Interleukin 17F (IL17F) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Interleukin 17F (IL17F) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 82-104% 90-98% 82-98% 86-96%
EDTA plasma(n=5) 83-104% 80-89% 78-90% 94-101%
heparin plasma(n=5) 80-101% 85-95% 80-104% 78-99%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:IL17F) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Cytokine Expression of IL-17A and IL-17F in lipopolysaccharide-induced acute lung injury and the counteraction of anisodamine or methylprednisolone ScienceDirect: S1043466614000040
Medical Sciences Cerebrospinal Fluid (CSF) IL-17A, IL-17F, IL-34 and CXCL-13 Levels in Amyotrophic Lateral Sclerosis (ALS/MND) Patients
Revista da Associacao Medica Brasileira A comparison of IL-17 and IL-34 concentrations in the cerebrospinal fluid of patients with acute inflammatory demyelinating neuropathy and chronic …
Hum Exp Toxicol Chrysene accelerates the proceeding of chronic obstructive pulmonary disease with the aggravation of inflammation and apoptosis in cigarette smoke exposed mice 33345606
Rev Assoc Med Bras A comparison of IL-17 and IL-34 concentrations in the cerebrospinal fluid of patients with acute inflammatory demyelinating neuropathy and chronic?¡­ 33295414
J Periodontol Cytokine profile in serum and gingival crevicular fluid of children with inflammatory bowel disease: A case‐control study 34730850
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
APB955Hu61 Active Interleukin 17F (IL17F) Cell culture; Activity Assays.
EPB955Hu61 Eukaryotic Interleukin 17F (IL17F) Positive Control; Immunogen; SDS-PAGE; WB.
RPB955Hu01 Recombinant Interleukin 17F (IL17F) Positive Control; Immunogen; SDS-PAGE; WB.
APB955Hu01 Active Interleukin 17F (IL17F) Cell culture; Activity Assays.
PAB955Hu01 Polyclonal Antibody to Interleukin 17F (IL17F) WB; IHC; ICC; IP.
LAB955Hu81 FITC-Linked Polyclonal Antibody to Interleukin 17F (IL17F) WB; IHC; ICC; IF.
LAB955Hu71 Biotin-Linked Polyclonal Antibody to Interleukin 17F (IL17F) WB; IHC; ICC.
MAB955Hu22 Monoclonal Antibody to Interleukin 17F (IL17F) WB; IHC; ICC; IP.
MAB955Hu23 Monoclonal Antibody to Interleukin 17F (IL17F) WB; IHC; ICC; IP.
MAB955Hu21 Monoclonal Antibody to Interleukin 17F (IL17F) WB.
SEB955Hu ELISA Kit for Interleukin 17F (IL17F) Enzyme-linked immunosorbent assay for Antigen Detection.
SCB955Hu CLIA Kit for Interleukin 17F (IL17F) Chemiluminescent immunoassay for Antigen Detection.
LMB955Hu Multiplex Assay Kit for Interleukin 17F (IL17F) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSB955Hu01 ELISA Kit DIY Materials for Interleukin 17F (IL17F) Main materials for "Do It(ELISA Kit) Yourself"